Literature DB >> 16187057

Rapid decrease of free vancomycin in dense staphylococcal cultures.

C Ekdahl1, H Hanberger, A Hällgren, M Nilsson, E Svensson, L E Nilsson.   

Abstract

Bacterial numbers in broth cultures were determined by bioluminescence assay of intracellular bacterial ATP. Broth MICs for strains of Staphylococcus epidermidis (ATCC 14990 and 35984) and Staphylococcus aureus (ATCC 25923, 29213 and 6538) were determined for cultures with different inocula (10(5)-10(8) bacteria/ml) after 24 h of incubation in supplemented Mueller-Hinton broth containing vancomycin. All of the tested strains except one were susceptible to methicillin, and all of the strains were susceptible to vancomycin. Free vancomycin concentrations in the broth cultures of all strains were determined with an agar well bioassay after 24 h of incubation. Free vancomycin concentrations and bacterial numbers of ATCC 35984 and ATCC 29213 were also determined after 0.5, 2, 4, and 8 h. In a low inoculum (10(5) bacteria/ml), the broth MICs were 1-4 microg/ml. In a high inoculum (approximately 10(8) bacteria/ml), the broth MICs increased two- to fourfold to 4-8 microg/ml. In dense inocula ( approximately 10(9)-10(10) bacteria/ml), the concentrations of free vancomycin in the broth were reduced, in most cases below the detection limit of the bioassay (</=0.5 microg/ml). This reduction of free vancomycin was fast, occurring in initially dense inocula in less than 30 min. No emergence of resistance was seen. These results show a rapid reduction of free vancomycin in the broth and a simultaneous increase in broth MICs in high inocula, without development of resistance. This indicates that the dosing regimen of vancomycin is of particular importance in staphylococcal infections with dense inocula, e.g. infective endocarditis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16187057     DOI: 10.1007/s10096-005-0011-0

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  14 in total

1.  Bacterial concentrations in pus and infected peritoneal fluid--implications for bactericidal activity of antibiotics.

Authors:  C König; H P Simmen; J Blaser
Journal:  J Antimicrob Chemother       Date:  1998-08       Impact factor: 5.790

2.  Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users.

Authors:  P M Small; H F Chambers
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

3.  Detection of bacteriuria by luciferase assay of adenosine triphosphate.

Authors:  A Thore; S Anséhn; A Lundin; S Bergman
Journal:  J Clin Microbiol       Date:  1975-01       Impact factor: 5.948

4.  Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus.

Authors:  K Sieradzki; A Tomasz
Journal:  J Bacteriol       Date:  1997-04       Impact factor: 3.490

5.  Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model.

Authors:  Kerry L LaPlante; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

6.  Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis.

Authors:  D P Levine; B S Fromm; B R Reddy
Journal:  Ann Intern Med       Date:  1991-11-01       Impact factor: 25.391

7.  In-vitro characteristics of glycopeptide resistant strains of Staphylococcus epidermidis isolated from patients on CAPD.

Authors:  D Sanyal; A P Johnson; R C George; R Edwards; D Greenwood
Journal:  J Antimicrob Chemother       Date:  1993-08       Impact factor: 5.790

8.  Minocycline versus vancomycin for treatment of experimental endocarditis caused by oxacillin-resistant Staphylococcus aureus.

Authors:  D P Nicolau; C D Freeman; C H Nightingale; C J Coe; R Quintiliani
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

9.  Novel membrane proteins present in teicoplanin-resistant, vancomycin-sensitive, coagulase-negative Staphylococcus spp.

Authors:  M D O'Hare; P E Reynolds
Journal:  J Antimicrob Chemother       Date:  1992-12       Impact factor: 5.790

10.  Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus.

Authors:  Longzhu Cui; Xiaoxue Ma; Katsuhiro Sato; Keiko Okuma; Fred C Tenover; Elsa M Mamizuka; Curtis G Gemmell; Mi-Na Kim; Marie-Cecile Ploy; N El-Solh; Vivian Ferraz; Keiichi Hiramatsu
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

View more
  4 in total

1.  Inoculum effects of ceftobiprole, daptomycin, linezolid, and vancomycin with Staphylococcus aureus and Streptococcus pneumoniae at inocula of 10(5) and 10(7) CFU injected into opposite thighs of neutropenic mice.

Authors:  Dong-Gun Lee; Yoichi Murakami; David R Andes; William A Craig
Journal:  Antimicrob Agents Chemother       Date:  2013-01-07       Impact factor: 5.191

2.  Mycotic aneurysm in a turtle hunter: brief review and a case report.

Authors:  Harsha Moole; Vamsi Krishna Emani; Shweta Ramsahai
Journal:  J Community Hosp Intern Med Perspect       Date:  2015-06-15

3.  Comparison of in vitro static and dynamic assays to evaluate the efficacy of an antimicrobial drug combination against Staphylococcus aureus.

Authors:  Diane C Broussou; Pierre-Louis Toutain; Frédérique Woehrlé; Farid El Garch; Alain Bousquet-Melou; Aude A Ferran
Journal:  PLoS One       Date:  2019-01-23       Impact factor: 3.240

4.  Differential Activity of the Combination of Vancomycin and Amikacin on Planktonic vs. Biofilm-Growing Staphylococcus aureus Bacteria in a Hollow Fiber Infection Model.

Authors:  Diane C Broussou; Marlène Z Lacroix; Pierre-Louis Toutain; Frédérique Woehrlé; Farid El Garch; Alain Bousquet-Melou; Aude A Ferran
Journal:  Front Microbiol       Date:  2018-03-27       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.